Thus, our results indicate diminished protein stability and an associated reduction in overall nucleolytic power of TREX1 as a plausible molecular explanation for why TREX1 P61Q mutations lead to severe AGS phenotypes in patients. Here, TREX1 is linked to Aicardi-Goutieres syndrome.